A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
Clinical trial NCT03268941 · COMPLETED
Trial details
- NCT number
- NCT03268941
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2018-03-09
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.